AUTHOR=Belik Milja , Liedes Oona , Vara Saimi , Haveri Anu , Pöysti Sakari , Kolehmainen Pekka , Maljanen Sari , Huttunen Moona , Reinholm Arttu , Lundberg Rickard , Skön Marika , Österlund Pamela , Melin Merit , Hänninen Arno , Hurme Antti , Ivaska Lauri , Tähtinen Paula A. , Lempainen Johanna , Kakkola Laura , Jalkanen Pinja , Julkunen Ilkka TITLE=Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose JOURNAL=Frontiers in Immunology VOLUME=Volume 14 - 2023 YEAR=2023 URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1099246 DOI=10.3389/fimmu.2023.1099246 ISSN=1664-3224 ABSTRACT=Abstract The prime-boost COVID-19 mRNA vaccination strategy has proven to be effective against severe COVID-19 disease and death. However, concerns have been raised due to decreasing neutralizing antibody levels after COVID-19 vaccination and due to the emergence of new immuno-evasive SARS-CoV-2 variants that may require additional booster vaccinations. Here we show that within the vaccinated health care workers (HCWs), the third mRNA vaccine dose recalls both humoral and T cell-mediated immune responses and induces high levels of neutralizing antibodies against Omicron BA.1 and BA.2 variants. Three weeks after the third vaccine dose, SARS-CoV-2 wild type spike protein-specific CD4+ and CD8+ T cells are observed in 82% and 71% of HCWs, respectively, and the T cells cross-recognize both Omicron BA.1 and BA.2 spike peptides. Although the levels of neutralizing antibodies against Omicron BA.1 and BA.2 decline 2.5 to 3.8-fold three months after the third dose, memory CD4+ T cell responses are maintained for at least eight months post the second dose and three months post the third vaccine dose suggesting durable immune protection.